RGD-Modified Endostatin Peptide 30 Derived from Endostatin Suppresses Invasion and Migration of HepG2 Cells Through the αvβ3 Pathway-Reference-Cited by-同舟云学术

RGD-Modified Endostatin Peptide 30 Derived from Endostatin Suppresses Invasion and Migration of HepG2 Cells Through the αvβ3 Pathway

Published:2011-10 Issue:5 Volume:26 Page:529-538
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Li Shuyan¹²,Wei Jing¹,Yuan Lijie¹,Sun Henan¹,Liu Yan¹,Zhang Yuwen¹,Li Jihong¹,Liu Xinghan¹³⁴

Affiliation:

1. Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China.

2. Department of Biochemistry and Molecular Biology, Qiqihar Medical University, Qiqihar, China.

3. Laboratory of Medical Genetics, Harbin Medical University, Harbin, China.

4. Bio-pharmaceutical Key Laboratory, Harbin Medical University, Ministry of Education, Harbin, China.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2011.0978

Reference25 articles.

1. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

2. Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action

3. A 27-Amino-Acid Synthetic Peptide Corresponding to the NH2-Terminal Zinc-Binding Domain of Endostatin Is Responsible for Its Antitumor Activity

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Effects of Anti-PD-L1 and Nanosonodynamic Therapy on HCC Immune Activation in Mice: An Investigation;International Journal of Nanomedicine;2024-07

2. Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer;Journal of Clinical Medicine;2023-02-27

3. Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells;J PHARM ANAL;2022

4. Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells;Journal of Pharmaceutical Analysis;2022-10

5. EnDuo, a novel derivative of Endostar, inhibits the migration of colon cancer cells, suppresses matrix metalloproteinase-2/9 expression and impedes AKT/ERK activation;Biomedicine & Pharmacotherapy;2021-02